IRADIMED CORPORATION to Hold Fourth Quarter of 2024, Full Year of 2024 Financial Results Conference Call on February 13, 2025

Core Viewpoint - Iradimed Corporation is set to release its 2024 fourth quarter financial results on February 13, 2025, and will host a conference call to discuss these results [1][2]. Company Overview - Iradimed Corporation specializes in developing innovative MRI-compatible medical devices, notably a non-magnetic intravenous infusion pump system designed for safe use during MRI procedures [3]. - The company was the first to create an infusion delivery system that mitigates risks associated with standard infusion pumps, which contain magnetic components that can interfere with MRI operations [3]. - The patented MRidium® MRI-compatible IV infusion pump utilizes a non-magnetic ultrasonic motor and non-ferrous parts to ensure safe and reliable delivery of anesthesia and IV fluids during MRI scans [3]. Product Features - The Iradimed 3880 MRI-compatible patient vital signs monitoring system is designed with non-magnetic components, allowing it to function in magnetic fields up to 30,000 gauss, ensuring patient safety during MRI procedures [4]. - This system features wireless ECG, SpO2 monitoring, non-magnetic respiratory CO2 measurement, and both invasive and non-invasive blood pressure monitoring, among other capabilities [4]. - The compact and lightweight design of the Iradimed 3880 allows for continuous monitoring of critically ill patients, reducing the time they spend away from critical care units [4].